Denali Capital Acquisition Corp. (DECA) Shareholders Approve Longevity Deal
Denali Capital (NASDAQ:DECA) announced this morning that its shareholders approved its combination with biotech firm Longevity during a special meeting yesterday, January 9.
The deal was overwhelmingly approved as holders of 5,196,327 shares voted in favor of the proposal while holders of just 10,100 shares cast their votes against it.
...READ MORE